Matcha During Pregnancy: Caffeine, Lead, and What the Guidelines Say
By Nick D · Founder, Steady Matcha
Published July 22, 2026
Matcha is not prohibited during pregnancy, but the guidance is to limit total caffeine to under 200mg per day (ACOG). A standard 2g matcha serving contains 60 to 80mg of caffeine, leaving room for 1 to 2 servings per day within that limit. Lead content is a separate concern: matcha absorbs lead from soil, and pregnant individuals should prioritize brands that publish third-party heavy metals test results. This is general information, not medical advice -- consult your healthcare provider.
Caffeine in matcha during pregnancy
The American College of Obstetricians and Gynecologists (ACOG) recommends limiting caffeine to less than 200mg per day during pregnancy. This is based on evidence linking high caffeine intake (above 200mg/day) to increased risk of fetal growth restriction and pregnancy loss.
A standard matcha serving (2g powder in 6 to 8oz water) contains approximately 60 to 80mg of caffeine. This means: - 1 serving of matcha: 60 to 80mg (within the 200mg limit) - 2 servings of matcha: 120 to 160mg (within the limit, but leaving little room for other caffeine sources) - 3 or more servings: may approach or exceed the 200mg limit
Total daily caffeine from all sources -- matcha, coffee, tea, chocolate, soft drinks -- must be counted together. If you drink matcha and also consume other caffeinated foods or beverages, the combined total matters.
Caffeine half-life increases significantly during pregnancy. In the third trimester, the half-life can reach 15 hours or more (compared to approximately 5 hours in non-pregnant adults). This means caffeine accumulates more readily and stays in the system longer, which is part of why the 200mg limit is conservative.
This is general information. Your healthcare provider can give guidance specific to your situation.
ACOG recommends limiting caffeine to less than 200mg per day during pregnancy - American College of Obstetricians and Gynecologists, 2023
Caffeine half-life in pregnancy (third trimester): up to 15 hours - Knutti et al., European Journal of Clinical Pharmacology, 1982
Lead in matcha during pregnancy
Lead is a separate concern from caffeine. Tea plants (Camellia sinensis) absorb lead from soil, and because matcha is made from whole ground leaves (not brewed and discarded), the lead content of the leaf is fully consumed.
The FDA has not established a specific limit for lead in matcha. California's Proposition 65 sets a Maximum Allowable Dose Level (MADL) for lead at 0.5 micrograms per day for reproductive toxicity. Some matcha products, particularly those from regions with higher soil lead levels, may contain lead levels that approach or exceed this threshold at typical serving sizes.
During pregnancy, lead exposure is of particular concern because lead crosses the placenta and can affect fetal neurological development. The CDC states there is no known safe level of lead exposure for children, and this concern extends to fetal exposure.
What this means practically: - Prioritize matcha brands that publish third-party heavy metals test results (Certificate of Analysis) - Brands that test and publish results allow you to verify actual lead levels per serving - Brands that do not publish results provide no way to verify lead content - Japanese-origin matcha from reputable growing regions generally has lower lead levels than some other origins, but this is not guaranteed without testing
This is general information. Discuss specific product choices with your healthcare provider.
California Prop 65 MADL for lead (reproductive toxicity): 0.5 micrograms per day - California OEHHA, 2023
L-theanine during pregnancy
Matcha contains L-theanine, an amino acid that modulates the caffeine effect. The research on L-theanine safety during pregnancy is limited. Most studies on L-theanine have been conducted in non-pregnant adults.
L-theanine is naturally present in all green tea, including matcha. At the amounts present in 1 to 2 servings of matcha (approximately 25 to 46mg per 2g serving), L-theanine is generally considered low-risk, but the evidence base for pregnancy-specific safety is not robust.
This is an area where consulting your healthcare provider is particularly important, as individual circumstances vary.
First trimester considerations
The first trimester is when the embryo is most sensitive to environmental exposures, including caffeine and lead. Some healthcare providers recommend being more conservative with caffeine in the first trimester, even below the 200mg/day limit.
Nausea is common in the first trimester and may make matcha unappealing. If you are experiencing morning sickness, the strong flavor of matcha may be difficult to tolerate.
If you were a regular matcha drinker before pregnancy, reducing to 1 serving per day in the first trimester is a conservative approach consistent with the ACOG guidance. Stopping entirely is also a valid choice.
This is general information, not medical advice.
Practical guidance for pregnant matcha drinkers
If you choose to drink matcha during pregnancy:
1. Count total daily caffeine from all sources and stay under 200mg 2. Choose brands that publish third-party heavy metals test results 3. Limit to 1 to 2 servings per day to stay within caffeine limits 4. Avoid matcha in the evening (caffeine half-life is extended during pregnancy) 5. Discuss your specific situation with your healthcare provider
If you are unsure about a specific brand's lead content, the Steady Matcha brand directory lists brands by testing transparency tier, making it easier to identify brands that publish COA results.
This is general information, not medical advice. Your healthcare provider is the appropriate source for guidance specific to your pregnancy.
Ready to make the switch?
Steady Matcha - ceremonial grade, Uji Japan, every batch lab-tested. Pre-order the founding batch.
Pre-order - $38Frequently Asked Questions
References
- Nutrition During Pregnancy - American College of Obstetricians and Gynecologists (2023)
- Caffeine intake during pregnancy and adverse birth outcomes - BMJ Evidence-Based Medicine (2021)
- Lead and Lead Compounds -- Proposition 65 - California OEHHA (2023)
- Caffeine kinetics in the pregnant woman, the neonate, and the infant - European Journal of Clinical Pharmacology (1982)
Last reviewed: